格帕沙星

格帕沙星（CAS 119914-60-2）的公开数据库记录，列此仅供独立核对。

危险化学品分类与危害说明

物理形态与操作说明

• Solid
• Grepafloxacin has in vitro activity against a wide range of gram-positive and gram-negative aerobic microorganisms, as well as some atypical microorganisms.

公开数据库收录的理化数据

这个物质在各数据库里的编号

数据库记载的用途

• For treatment of adults with mild to moderate infections caused by susceptible strains of Haemophilus influenzae, Streptococcus pneumoniae, or Moraxella catarrhalis.
• Take with or without food. The absorption is unaffected by food.
• Substances that inhibit the growth or reproduction of BACTERIA.
• Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.
• J - Antiinfectives for systemic use
• J01 - Antibacterials for systemic use

它在各数据库里的别名

Grepafloxacin; 119914-60-2; 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; Grepafloxacine; Grepafloxacino; 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; L1M1U2HC31; 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-; OPC-17116; DTXSID2048321; grepafloxacinum; RefChem:922501; DTXCID0028296; J01MA11; (+--)-1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; (RS)-1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid

计算机算出的分子描述符

数据库摘要

Grepafloxacin · CAS 119914-60-2 · C19H22FN3O3. UNII L1M1U2HC31. 溶解度: 6.32e-01 g/L; LogP: 2.9.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。